Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAin Shams University

About this trial

This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 18 to 70 years old.

Both sexes.

Septic patients (under the third international consensus definitions of sepsis and septic shock).

Disqualifiers

Pregnancy

Malignancy

On immunosuppressive therapy

Hematological Disorders

Trial population

A prospective observational study will be conducted at Ain Shams University Hospital, Cairo, Egypt.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Neutrophils to Lymphocytes and Platelets ratio (N/LP)

    Diagnostic test

    The Neutrophils to Lymphocytes and Platelets ratio (N/LP) will be measured

Treatment groups

290 Participants
are divided into 1 treatment group
Group A: Study group1 intervention

Trial outcomes

Primary outcomes

1

Levels of Neutrophils to Lymphocytes and Platelets ratio

The ratio of neutrophils to Lymphocytes and Platelets in relation to 28-day mortality among septic patients will be recorded.

Time frame
28 days post-procedure

Secondary outcomes

1

Procalcitonin (PCT)

Procalcitonin (PCT) in relation to 28day mortality among septic patients will be recorded.

Time frame
28 days post-procedure
2

Total Leukocytic Count (TLC)

Total Leukocytic Count (TLC) in relation to 28day mortality among septic patients will be recorded.

Time frame
28 days post-procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.